Alger Focus Equity Z (ALZFX)

Nasdaq • Currently up 0.40 (+0.33%) in today's trading session

1 member of Congress has disclosed 1 trade in Alger Focus Equity Z (ALZFX) via STOCK Act filings. The most recent disclosure was a purchase by Chris Pappas on 18 August 2025. Aggregate disclosed activity totals roughly $32.5K in purchases (midpoint estimates from bracketed disclosure amounts).

Alger Focus Equity Z is currently trading at $122.16, positioned at 86% of its 52-week range ($92.76 – $127.04).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$122.16
24h Change
+0.40 (+0.33%)
52 Week Range
$92.76—$127.04
View on NASDAQ

Alger Focus Equity Z Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ALZFX

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$618.02M

Volume

0

Beta

1.51

P/E Ratio

45.31

Fundamentals

EPS

$2.70

Div. Yield

6.62%

Open

$122.16

Day Range

$122.16 — $122.16

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
CEO
Daniel C. ChungBiography
IPO Date
2012-12-31
Website
www.allianzgi.com

The advisor intends to invest a substantial portion of its assets in a smaller number of issuers. Generally, the fund will own approximately 50 holdings. Fund holdings may occasionally differ from this number for a variety of reasons. The fund may en...

No earnings data available for this stock.

Dividends

Dividend History

17 Dec 2025
Amount $8.0851
14 Dec 2023
Amount $0.0661
15 Dec 2022
Amount $0.0360
15 Dec 2021
Amount $7.9638
16 Dec 2020
Amount $3.4070
18 Dec 2019
Amount $0.8880
18 Dec 2018
Amount $1.7010
15 Dec 2017
Amount $1.2260

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ALZFX

Which members of Congress have traded ALZFX?
1 member of Congress has disclosed 1 trade in Alger Focus Equity Z (ALZFX) under the STOCK Act: Chris Pappas.
When was ALZFX most recently disclosed by Congress?
The most recent ALZFX disclosure was a purchase by Chris Pappas on 18 August 2025.
What is the total disclosed congressional trading volume for ALZFX?
Members of Congress have disclosed approximately $32.5K in ALZFX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ALZFX?
This ALZFX page updates as soon as new STOCK Act disclosures are filed for Alger Focus Equity Z. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.